Avg closing price
Price range

2 David Einhorn Gain Therapeutics Trades

David Einhorn's position in Gain Therapeutics is currently worth $2.72 Million. That's 0.13% of their equity portfolio (33rd largest holding). The investor owns 3.00% of the outstanding Gain Therapeutics stock. The investor's estimated purchase price is $7.33 Million, resulting in a loss of 63%.

Avg closing price
Price range
Increased shares by 7.7% (+41.9 Thousand shares) Q3 2023
Avg closing price $3.79
Price range $3.19 - $4.68
New holding (+547 Thousand shares) Q1 2021
Avg closing price $13.12
Price range $11.20 - $14.92

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!